Association of epiretinal membranes with disability in people with multiple sclerosis

Ting-Yi Lin1, Anna Bacchetti1, Brenna McCormack1

  • 1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|July 6, 2026
PubMed
Abstract

Insights

Epiretinal membranes (ERMs) were found in 18.4% of people with multiple sclerosis (PwMS), correlating with increased disability and retinal thinning. ERMs may indicate a distinct MS phenotype linked to central nervous system processes.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Immunology

Background:

  • Epiretinal membranes (ERMs) are fibrocellular growths potentially linked to glial activation and retinal pigment epithelium (RPE) migration.
  • The clinical significance of ERMs in people with multiple sclerosis (PwMS) is not well understood.

Purpose of the Study:

  • To determine the prevalence of ERMs in PwMS.
  • To examine the association between ERMs, retinal layer thickness, and disability in PwMS.

Main Methods:

  • A cohort of PwMS with ERMs (ERM+) was compared to a matched cohort of PwMS without ERMs (ERM-).
  • Matching criteria included optic neuritis history, MS subtype, age, sex, and race.
  • Disability was assessed using measures like the Expanded Disability Status Scale (EDSS), walking speed, manual dexterity, and processing speed tests.

Main Results:

  • ERMs were detected in 18.4% of PwMS, compared to 11.8% of healthy controls.
  • ERM+ PwMS showed significantly higher EDSS scores, slower walking and manual dexterity tests, and reduced processing speed and low-contrast letter acuity.
  • ERM+ PwMS also exhibited thinner retinal layers, including the ganglion cell-inner plexiform, inner nuclear, outer nuclear, and RPE layers.
  • Higher ERM stage correlated with increased disability.

Conclusions:

  • ERMs may signify a unique multiple sclerosis (MS) phenotype associated with microglial/macroglial activity.
  • The presence of ERMs could serve as a biomarker for widespread central nervous system pathology contributing to greater disability in PwMS.